Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1942
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies ; volume:44 ; number:4 ; day:6 ; month:2 ; year:2021 ; pages:467-478 ; date:4.2021
Drug safety ; 44, Heft 4 (6.2.2021), 467-478, 4.2021
- Creator
-
FitzGerald, J. Mark
O’Byrne, Paul M.
Bateman, Eric D.
Barnes, Peter J.
Zheng, Jinping
Ivanov, Stefan
Lamarca, Rosa
Larsdotter, Ulrika
Emerath, Ulrika
Jansen, Gerreke
Puu, Margareta
Alagappan, Vijay K. T.
Surmont, Filip
Reddel, Helen K.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40264-020-01041-z
- URN
-
urn:nbn:de:101:1-2021050922270267161363
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- FitzGerald, J. Mark
- O’Byrne, Paul M.
- Bateman, Eric D.
- Barnes, Peter J.
- Zheng, Jinping
- Ivanov, Stefan
- Lamarca, Rosa
- Larsdotter, Ulrika
- Emerath, Ulrika
- Jansen, Gerreke
- Puu, Margareta
- Alagappan, Vijay K. T.
- Surmont, Filip
- Reddel, Helen K.
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol
Budesonide/Glycopyrronium/Formoterol: A Review in COPD
Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
Effect of adjusting the combination of budesonide/formoterol on the alleviation of asthma symptoms
Correction to: A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®
Budesonide/Formoterol Easyhaler®: Performance Under Simulated Real-Life Conditions
Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol
Budesonide/Glycopyrronium/Formoterol: A Review in COPD
Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
Effect of adjusting the combination of budesonide/formoterol on the alleviation of asthma symptoms
Correction to: A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®
Budesonide/Formoterol Easyhaler®: Performance Under Simulated Real-Life Conditions
Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol
Budesonide/Glycopyrronium/Formoterol: A Review in COPD
Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
Effect of adjusting the combination of budesonide/formoterol on the alleviation of asthma symptoms
Correction to: A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®
Budesonide/Formoterol Easyhaler®: Performance Under Simulated Real-Life Conditions
Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD